Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Conference Coverage

RSNA: Conversations From the Conference Floor - Part 3

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th in Chicago.

    Host Dr. Jason Birnholz talks with Dr. Rozemarijn Vliegenthart, from the University Medical Center Groningen in the Netherlands, who presented at the conference a paper entitled, "High Prevalence of Treatable Severe Coronary Artery Disease: Findings in a Randomized Controlled Trial in Cardiac Asymptomatic Peripheral Arterial Disease Patients." Dr. Birnholz also sits down with Dr. Asim F. Choudhri, from Johns Hopkins University in Baltimore, to talk about tele-radiology and smartphones.

Recommended
Details
Presenters
Comments
  • Overview

    These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th in Chicago.

    Host Dr. Jason Birnholz talks with Dr. Rozemarijn Vliegenthart, from the University Medical Center Groningen in the Netherlands, who presented at the conference a paper entitled, "High Prevalence of Treatable Severe Coronary Artery Disease: Findings in a Randomized Controlled Trial in Cardiac Asymptomatic Peripheral Arterial Disease Patients." Dr. Birnholz also sits down with Dr. Asim F. Choudhri, from Johns Hopkins University in Baltimore, to talk about tele-radiology and smartphones.

Schedule22 Nov 2024